Cardiometabolic disorders and weight: A complex constellation of interrelated conditions

Article

This constellation of conditions-cardiometabolic disorders and weight-has become one of the most pressing public health issues today, affecting approximately a quarter of the U.S. population, accounting for a substantial proportion of health-care and prescription drug spending, and threatening the vitality of an aging population.

Key Points

An estimated 47 million Americans have double the average risk of heart disease because they are affected by a complex constellation of interrelated conditions, including obesity, impaired glucose metabolism, hypertension, and lipid disorders.1 These patients also are five times more likely to develop diabetes, according to the National Heart, Lung, and Blood Institute.1

This constellation of conditions-cardiometabolic disorders and weight (CMDW)-has become one of the most pressing public health issues today, affecting approximately a quarter of the U.S. population, accounting for a substantial proportion of health-care and prescription drug spending, and threatening the vitality of an aging population.1,2

Obesity

Recent research indicates that excess visceral adipose tissue releases metabolites, cytokines, chemokines, and hormones that influence inflammation and other factors to affect atherogenesis and the vessel wall directly.6

In an effort to slow the obesity epidemic, 19 states have set stricter nutritional standards for school meals, 27 states have nutritional standards for foods sold in schools, and 20 now require body mass index screening or other weight assessment of schoolchildren.7

Impaired glucose metabolism

In the United States, 17.9 million patients have diagnosed diabetes; an estimated 5.7 million cases remain undiagnosed, and an additional 57 million people have prediabetes, according to the American Diabetes Association.8 The incidence of diabetes among those aged 60 years or more is 23.1%. An estimated 16.5% of the adult American Indian and Alaska native population are affected by diabetes.8 After adjusting for age differences, the prevalence of diabetes is 11.8% among non-Hispanic blacks, 10.4% among Hispanic Americans, 7.5% in Asian Americans, and 6.6% among non-Hispanic whites.8

Overall, approximately 210,000 Americans aged more than 20 years have diabetes, an incidence of 0.26%, but the data do not differentiate between diabetes types.8 Type 2 diabetes, however, is being diagnosed more frequently in children, especially among Native Americans and African and Hispanic Americans. In addition, one in six overweight adolescents-approximately 2 million-have prediabetes.8

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD; detailed what optometrists can expect to change when HB 1353's regulations are enacted later this year.
Arkansas Optometric Association legislative cochairs Matt Jones, OD; Matt Burns, OD; and Joe Sugg, OD, discuss their involvement in their bill and provide context for its relevance.
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Dana Shannon, OD, FAAO, shares pearls on spotting red flags in need of referral and enhancing patient care with follow-up compliance.
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
© 2025 MJH Life Sciences

All rights reserved.